The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Oxford Instruments-TDI acquires IP rights from Fox Grp

October 26, 2010 7:33 pm | by I-Micronews | News | Comments

Oxford Instruments-TDI, a world leader in the development of Hydride Vapour Phase Epitaxy (HVPE) processes and techniques for the production of novel compound semiconductors such as GaN, AlN, AlGaN, InN, InGaN, has just entered into a licensing agreement with The Fox Group.

IC maker Power Integrations invests $30m in SiC device firm SemiSouth

October 26, 2010 7:33 pm | by I-Micronews | News | Comments

Power Integrations Inc of San Jose, CA, USA, which supplies high-voltage integrated circuits for compact, energy-efficient AC-DC and DC-DC power conversion in electronic products, has made a strategic investment in SemiSouth Laboratories Inc of Starkville, MS, USA.

Teleflex reports drop in 3Q income, higher revenue

October 26, 2010 4:45 pm | by The Associated Press | News | Comments

Teleflex, Inc., a maker of medical and aerospace equipment, reported Tuesday that its third-quarter income plummeted 42 percent, after the company paid down some of its debt and invested in research and development.The company's earnings fell to $22.2 million, or 55 cents per share, from income...


Following lifestyle tips could prevent almost a quarter of bowel cancer cases

October 26, 2010 3:34 pm | by EurekAlert | News | Comments

(BMJ-British Medical Journal) Almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise, says a new study published on today.


McKesson earnings rise; $1 bln buyback announced

October 26, 2010 2:45 pm | by The Associated Press | News | Comments

Medical supply firm McKesson Corp. reported higher fiscal second-quarter profit and sales Tuesday that fell short of Wall Street expectations. The company announced a $1 billion buyback, however, and its stock price jumped more than 5 percent after hours.McKesson posted net income of $327...

WHO pesticide regulations should be based on toxicity in humans, not rats

October 26, 2010 1:33 pm | by EurekAlert | News | Comments

(Public Library of Science) Current WHO pesticide classifications are based on toxicity in rats but basing regulation on human toxicity will make pesticide poisoning less hazardous and prevent hundreds of thousands of deaths globally without compromising agricultural needs.


Mosquito monitoring saves lives and money, analysis finds

October 26, 2010 1:33 pm | by EurekAlert | News | Comments

(Emory University) Cutting surveillance for mosquito-borne diseases would likely translate into an exponential increase in both the number of human cases and the health costs when a disease outbreak occurs, according to an analysis by Emory University. The research was prompted by...


Boston Scientific Completes Acquisition of Asthmatx

October 26, 2010 1:31 pm | by Boston Scientific | News | Comments

NATICK, Mass., Oct. 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of Asthmatx, Inc. of Sunnyvale, California.  The transaction follows the definitive


MEI Development Acquires Oncology Group; Names Founder as Head of Oncology Division

October 26, 2010 1:31 pm | by Bio-Medicine.Org | News | Comments

CORAL SPRINGS, Fla., Oct. 26 /- Florida-based MEI Development Corporation, a subsidiary of The MEI Healthcare Group (MEI), has acquired Georgia-based Oncology Business Advisory Group (OBAG) and named one of OBAG's founding partners, Cathy Putnick, as head of MEI Oncology Services....


12 Tips to Outsourcing Development Success

October 26, 2010 12:47 pm | by Tim Bosch and David Ennen | Articles | Comments

More medical device OEMs are outsourcing a portion or the entire product development process than ever before. However, when relying on a vendor partner to achieve a successful outcome, OEMs must ensure clear communication is established and maintained. This article provides 12 tips to accomplish this.

Neurocrine Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference

October 26, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 26 /- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Oppenheimer 21st Annual Healthcare Conference in New York.   The live presentation takes...


Infinity Pharma pain treatment finds marketing help from alliance

October 26, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Development and commercialization of a treatment for inflammatory diseases developed by Infinity Pharmaceuticals Inc. is moving to Purdue Pharmaceutical Products LP and Mundipharma International Corp. Ltd., as part of an alliance formed by the companies in 2008.


Resolvyx, Celtic Pharma form deal around dry eye therapy

October 26, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Resolvyx Pharmaceuticals Inc., a Bedford-based developer of anti-inflammatory drugs, and Celtic Pharma, based in the U.S. Virgin Islands, have entered into a deal relating to Resolvyx’s dry-eye syndrome treatment.

Class I Medical Device Recall: Excelsior Medical Disposable Syringe with Normal Saline (0.9% Sodium Chloride, 5mL fill in 6mL syringe)

October 26, 2010 10:33 am | by U.S. Food & Drug Administration | News | Comments

The Excelsior Disposable 5mL fill in 6mL prefilled saline flush syringes are intended for the flushing of venous access devices (such as, inserted central catheters) and intravenous (IV) lines.

BU robotics research aims to straighten gaits

October 26, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

A Boston University professor has developed a robotics device designed to help prevent hip damage created by an incorrect gait. The goal is to correct a healthy patient’s walking gait early on so osteoarthritis doesn’t develop later in life.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.